301 related articles for article (PubMed ID: 34233978)
1. Safety of topical corticosteroids in atopic eczema: an umbrella review.
Axon E; Chalmers JR; Santer M; Ridd MJ; Lawton S; Langan SM; Grindlay DJC; Muller I; Roberts A; Ahmed A; Williams HC; Thomas KS
BMJ Open; 2021 Jul; 11(7):e046476. PubMed ID: 34233978
[TBL] [Abstract][Full Text] [Related]
2. Strategies for using topical corticosteroids in children and adults with eczema.
Lax SJ; Harvey J; Axon E; Howells L; Santer M; Ridd MJ; Lawton S; Langan S; Roberts A; Ahmed A; Muller I; Ming LC; Panda S; Chernyshov P; Carter B; Williams HC; Thomas KS; Chalmers JR
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013356. PubMed ID: 35275399
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
[TBL] [Abstract][Full Text] [Related]
5. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
Green C; Colquitt JL; Kirby J; Davidson P; Payne E
Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
[TBL] [Abstract][Full Text] [Related]
6. The long-term safety of topical corticosteroids in atopic dermatitis: A systematic review.
Harvey J; Lax SJ; Lowe A; Santer M; Lawton S; Langan SM; Roberts A; Stuart B; Williams HC; Thomas KS
Skin Health Dis; 2023 Oct; 3(5):e268. PubMed ID: 37799373
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.
Schmitt J; von Kobyletzki L; Svensson A; Apfelbacher C
Br J Dermatol; 2011 Feb; 164(2):415-28. PubMed ID: 20819086
[TBL] [Abstract][Full Text] [Related]
8. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
Chu DK; Chu AWL; Rayner DG; Guyatt GH; Yepes-Nuñez JJ; Gomez-Escobar L; Pérez-Herrera LC; Díaz Martinez JP; Brignardello-Petersen R; Sadeghirad B; Wong MM; Ceccacci R; Zhao IX; Basmaji J; MacDonald M; Chu X; Islam N; Gao Y; Izcovich A; Asiniwasis RN; Boguniewicz M; De Benedetto A; Capozza K; Chen L; Ellison K; Frazier WT; Greenhawt M; Huynh J; LeBovidge J; Lio PA; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Smith Begolka W; Wang J; Wheeler KE; Gardner DD; Schneider L
J Allergy Clin Immunol; 2023 Dec; 152(6):1493-1519. PubMed ID: 37678572
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Interventions for hand eczema.
Christoffers WA; Coenraads PJ; Svensson Å; Diepgen TL; Dickinson-Blok JL; Xia J; Williams HC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004055. PubMed ID: 31025714
[TBL] [Abstract][Full Text] [Related]
11. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema.
Matterne U; Böhmer MM; Weisshaar E; Jupiter A; Carter B; Apfelbacher CJ
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012167. PubMed ID: 30666626
[TBL] [Abstract][Full Text] [Related]
12. Different potencies of topical corticosteroids for a better treatment strategy in children with atopic dermatitis (the Rotterdam Eczema study): protocol for an observational cohort study with an embedded randomised open-label controlled trial.
van Halewijn KF; Bohnen AM; van den Berg PJ; Pasmans SGMA; Bindels PJE; Elshout G
BMJ Open; 2019 Jun; 9(6):e027239. PubMed ID: 31221882
[TBL] [Abstract][Full Text] [Related]
13. Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use.
Green C; Colquitt JL; Kirby J; Davidson P
Br J Dermatol; 2005 Jan; 152(1):130-41. PubMed ID: 15656813
[TBL] [Abstract][Full Text] [Related]
14. Systematic review of treatments for atopic eczema.
Hoare C; Li Wan Po A; Williams H
Health Technol Assess; 2000; 4(37):1-191. PubMed ID: 11134919
[TBL] [Abstract][Full Text] [Related]
15. Topical pimecrolimus for eczema.
Ashcroft DM; Chen LC; Garside R; Stein K; Williams HC
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005500. PubMed ID: 17943859
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene receptor antagonists for eczema.
Ferguson L; Futamura M; Vakirlis E; Kojima R; Sasaki H; Roberts A; Mori R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011224. PubMed ID: 30343498
[TBL] [Abstract][Full Text] [Related]
17. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
Silverberg JI; Adam DN; Zirwas M; Kalia S; Gutermuth J; Pinter A; Pink AE; Chiricozzi A; Barbarot S; Mark T; Tindberg AM; Weidinger S
Am J Clin Dermatol; 2022 Jul; 23(4):547-559. PubMed ID: 35857179
[TBL] [Abstract][Full Text] [Related]
18. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
[TBL] [Abstract][Full Text] [Related]
19. Phototherapy for atopic eczema.
Musters AH; Mashayekhi S; Harvey J; Axon E; Lax SJ; Flohr C; Drucker AM; Gerbens L; Ferguson J; Ibbotson S; Dawe RS; Garritsen F; Brouwer M; Limpens J; Prescott LE; Boyle RJ; Spuls PI
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013870. PubMed ID: 34709669
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
Garside R; Stein K; Castelnuovo E; Pitt M; Ashcroft D; Dimmock P; Payne L
Health Technol Assess; 2005 Jul; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
